IBDEI0HK ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8497,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,8498,0)
 ;;=202.81^^52^582^61
 ;;^UTILITY(U,$J,358.3,8498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8498,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,8498,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,8498,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,8499,0)
 ;;=215.9^^52^582^85
 ;;^UTILITY(U,$J,358.3,8499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8499,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,8499,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,8499,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,8500,0)
 ;;=224.2^^52^582^51
 ;;^UTILITY(U,$J,358.3,8500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8500,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,8500,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,8500,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,8501,0)
 ;;=224.5^^52^582^96
 ;;^UTILITY(U,$J,358.3,8501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8501,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,8501,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,8501,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,8502,0)
 ;;=224.7^^52^582^28
 ;;^UTILITY(U,$J,358.3,8502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8502,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,8502,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,8502,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,8503,0)
 ;;=237.70^^52^582^66
 ;;^UTILITY(U,$J,358.3,8503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8503,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,8503,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,8503,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,8504,0)
 ;;=239.6^^52^582^65
 ;;^UTILITY(U,$J,358.3,8504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8504,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,8504,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,8504,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,8505,0)
 ;;=239.81^^52^582^97
 ;;^UTILITY(U,$J,358.3,8505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8505,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,8505,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,8505,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,8506,0)
 ;;=272.0^^52^582^48
 ;;^UTILITY(U,$J,358.3,8506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8506,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,8506,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,8506,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,8507,0)
 ;;=340.^^52^582^63
 ;;^UTILITY(U,$J,358.3,8507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8507,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,8507,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,8507,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,8508,0)
 ;;=345.90^^52^582^29
 ;;^UTILITY(U,$J,358.3,8508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8508,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,8508,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,8508,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,8509,0)
 ;;=368.02^^52^582^23
 ;;^UTILITY(U,$J,358.3,8509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8509,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,8509,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,8509,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,8510,0)
 ;;=368.11^^52^582^103
 ;;^UTILITY(U,$J,358.3,8510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8510,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,8510,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,8510,2)
 ;;=^268831
 ;;^UTILITY(U,$J,358.3,8511,0)
 ;;=368.59^^52^582^11
 ;;^UTILITY(U,$J,358.3,8511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8511,1,3,0)
 ;;=3^Color Blindness
